NYLT
PFE icon

New York Life Trust’s Pfizer PFE Stock Holding History

New York Life Trust’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$24K Sell
747
-8,618
-92% -$272K 1.17% 13
2016
Q4 		$289K Sell
9,365
-186
-2% -$5.68K 1.37% 13
2016
Q3 		$307K Buy
9,551
+44
+0.5% +$1.47K 1.52% 12
2016
Q2 		$318K Buy
9,507
+1,363
+17% +$43.5K 1.54% 11
2016
Q1 		$229K Sell
8,144
-2,494
-23% -$71.2K 0.99% 26
2015
Q4 		$326K Sell
10,638
-71
-0.7% -$2.23K 1.4% 10
2015
Q3 		$319K Sell
10,709
-1,069
-9% -$34.3K 1.42% 9
2015
Q2 		$375K Sell
11,778
-669
-5% -$21.8K 1.56% 8
2015
Q1 		$411K Sell
12,447
-521
-4% -$16.6K 1.64% 7
2014
Q4 		$383K Sell
12,968
-42
-0.3% -$1.2K 1.51% 7
2014
Q3 		$365K Buy
13,010
+136
+1% +$3.82K 1.51% 9
2014
Q2 		$363K Buy
12,874
+616
+5% +$17.6K 1.53% 9
2014
Q1 		$374K Sell
12,258
-82
-0.7% -$2.44K 1.65% 8
2013
Q4 		$359K Sell
12,340
-65
-0.5% -$1.89K 1.63% 7
2013
Q3 		$338K Sell
12,405
-1,958
-14% -$53.3K 1.69% 8
2013
Q2 		$382K Buy
+14,363
New +$397K 1.76% 10

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

New York Life Trust's PFE Position: Q1 2017 in Review

New York Life Trust reduced its Pfizer (PFE) stake by 92% in Q1 2017, selling an estimated $272K and leaving 747 shares worth $24K. The position accounts for 1.17% of the portfolio, ranked #13.

New York Life Trust first reported a position in PFE in Q2 2013 and has held it in 16 quarters since. The position peaked at $411K in Q1 2015. 2,075 funds tracked by Wall St. Rank hold PFE as of Q1 2017.

  • New York Life Trust held 747 shares of Pfizer worth $24K as of Q1 2017.
  • New York Life Trust sold 8,618 Pfizer shares in Q1 2017, an estimated $272K.
  • Pfizer made up 1.17% of New York Life Trust's portfolio in Q1 2017, its #13 holding.
  • New York Life Trust first reported a position in Pfizer in Q2 2013 and has held it in 16 quarters since.
  • New York Life Trust's Pfizer position peaked at $411K in Q1 2015.
  • 2,075 funds tracked by Wall St. Rank held Pfizer as of Q1 2017.

Based on New York Life Trust's 13F filing for Q1 2017, filed 12 May 2017.